Pharmaceutical Investing

Kura Gets US Patent for Clinical-Stage Drug

Pharmaceutical Investing

Evoke Inks Partnership with Spaulding Clinical Research For Trial

Pharmaceutical Investing

Cellectar Receives Patent Approval in Japan

Pharmaceutical Investing

Mateon Shows Results from Interim Analysis of FOCUS Study

Pharmaceutical Investing

Protalix Reveals New Preclinical Data for PRX-102

Pharmaceutical Investing

Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial

Biotech Investing

Immunovaccine Begins Dosing on Clinical Trial

Pharmaceutical Investing

Prometic's Clinical Trial Gets FDA Approval

Pharmaceutical Investing

An Introduction to TSXV Life Science Stocks

Biotech Investing

Arch's Anti-Bacterial Candidate to Enter Phase I Trial

Pharmaceutical Investing

IntelGenx and RedHill Get Marketing Approval in Luxembourg

Pharmaceutical Investing

DelMar Pharmaceuticals Announces Pricing Of $9,000,000 Public Offering Of Common Stock And Warrants

Life Science Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES